N
Ecosystem Profile
NanoTess
Develops technology to treat chronic wounds with a topical gel containing micron-scale catalysts.
Canadian Venture (AB)1
Dispatches
Apr 15, 2026
Last Signal
Full Coverage Archive
Catalytic Breakthrough: How NanoTess is Redefining Chronic Wound Care in Canadian Healthcare
Catalytic Gel/biotechnologyApr 15, 20262 min
Catalytic Breakthrough: How NanoTess is Redefining Chronic Wound Care in Canadian Healthcare
From the outset, NanoTess, under the visionary leadership of Megan Leslie, has focused not merely on treating symptoms, but on addressing the fundamental biochemistry of stalled healing. The conceptual genius...
↗ NanoTess's breakthrough is not a mere wound dressing; it is a biocompatible catalyst that reactivates the body's own healing mechanisms, promising significant cost reductions and dramatically improved outcomes for chronic, hard-to-heal wounds across Canada.